Menopausal Hormone Therapy Can Significantly Increase Women's Risk of CRC

An updated analysis performed by the Women's Health Initiative revealed that menopausal hormone therapy with estrogen and progestin can significantly increase a woman's risk of death from several types of cancers, including colorectal cancer, according to the study's abstract.

Specifically, WHI found there was a 54 percent increased risk of death after a colorectal cancer diagnosis when female patients were randomized to combined hormone therapy compared to placebo trials. Although a few number of colorectal cancers resulted from the combined-therapy group, the group was at higher risk of mortality.

Read the abstract on menopausal hormone therapy and CRC.

Read other coverage about colorectal cancer:

- Studies Show Mailed and Electronic Reminders Increase Colorectal Cancer Screening Rates

- Study Suggests Hormone Therapy Could Increase Risk of CRC by Up To 40%

- 10 Recent Studies and Breakthroughs Impacting Gastroenterology/Endoscopy

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast